Bruker Corporation (BRKR) to Issue Quarterly Dividend of $0.05 on January 2nd

Bruker Corporation (NASDAQ:BRKR) declared a quarterly dividend on Tuesday, November 4th. Shareholders of record on Monday, December 8th will be paid a dividend of 0.05 per share by the medical research company on Friday, January 2nd. This represents a c) dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Monday, December 8th.

Bruker has increased its dividend payment by an average of 0.0%annually over the last three years. Bruker has a payout ratio of 7.3% meaning its dividend is sufficiently covered by earnings. Analysts expect Bruker to earn $3.15 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 6.3%.

Bruker Price Performance

BRKR opened at $40.20 on Thursday. The company’s 50-day simple moving average is $34.78 and its two-hundred day simple moving average is $37.04. The company has a debt-to-equity ratio of 1.31, a quick ratio of 0.70 and a current ratio of 1.61. The stock has a market capitalization of $6.10 billion, a P/E ratio of 77.31, a P/E/G ratio of 5.31 and a beta of 1.26. Bruker has a 52-week low of $28.53 and a 52-week high of $64.64.

Bruker (NASDAQ:BRKR) last released its quarterly earnings data on Monday, November 3rd. The medical research company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.12. The firm had revenue of $860.50 million during the quarter, compared to analysts’ expectations of $847.40 million. Bruker had a net margin of 2.31% and a return on equity of 17.89%. The firm’s quarterly revenue was down .5% on a year-over-year basis. During the same period in the previous year, the company earned $0.60 earnings per share. Bruker has set its FY 2025 guidance at 1.850-1.90 EPS. As a group, analysts predict that Bruker will post 2.69 EPS for the current year.

Insider Activity at Bruker

In other news, Director Cynthia M. Friend sold 3,535 shares of Bruker stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $32.25, for a total transaction of $114,003.75. Following the transaction, the director directly owned 18,016 shares of the company’s stock, valued at $581,016. The trade was a 16.40% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 27.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On Bruker

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC lifted its holdings in Bruker by 377.5% during the second quarter. Nisa Investment Advisors LLC now owns 616 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 487 shares in the last quarter. Allworth Financial LP raised its position in shares of Bruker by 92.4% during the 1st quarter. Allworth Financial LP now owns 758 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 364 shares during the period. Huntington National Bank lifted its stake in shares of Bruker by 750.0% during the 2nd quarter. Huntington National Bank now owns 731 shares of the medical research company’s stock valued at $30,000 after buying an additional 645 shares in the last quarter. Spire Wealth Management purchased a new position in shares of Bruker during the 2nd quarter valued at $32,000. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in Bruker by 1,354.5% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 800 shares of the medical research company’s stock worth $33,000 after buying an additional 745 shares during the period. Institutional investors own 79.52% of the company’s stock.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.